RankingsPricing
  1. US-listed companies
  2. WEST PHARMACEUTICAL SERVICES INC
  3. Financials
  4. Cash from financing

WEST PHARMACEUTICAL SERVICES INCWST

Market cap
$19.7B
P/E ratio
SummaryFinancials
Period EndCash from financing (Million USD)YoY (%)
Dec 31, 2024-623+35.47%
Dec 31, 2023-460+56.54%
Dec 31, 2022-294+74.66%
Dec 31, 2021-168+22.61%
Dec 31, 2020-137+272.55%
Dec 31, 2019-37-54.40%
Dec 31, 2018-81-25.96%
Dec 31, 2017-109-4.30%
Dec 31, 2016-114+174.46%
Dec 31, 2015-41+34.74%
Dec 31, 2014-31+503.92%
Dec 31, 2013-5+50.00%
Dec 31, 2012-3-90.00%
Dec 31, 2010-34

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)